Trial Profile
ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Apr 2022
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary) ; Valganciclovir
- Indications Cytomegalovirus infections; Epstein-Barr virus infections
- Focus Therapeutic Use
- 08 Sep 2021 Status changed from active, no longer recruiting to completed.
- 02 Dec 2019 Planned End Date changed from 1 Nov 2019 to 31 Oct 2020.
- 02 Dec 2019 Planned primary completion date changed from 1 Nov 2019 to 31 Oct 2020.